News

PrandiMet is a meglitinide and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who

According to the results of an internal review conducted at the clinical site, and a second review by the trial’s independent data safety monitoring board, this event has

In this newly created role, Dr Currie will drive partnering, licensing, companion diagnostics, and corporate business development activities at Sirs-Lab. Dr Currie, a physician specialized in clinical microbiology

Dale VanderPutten, CEO of Omnia Biologics, said: “The team at Omnia is very pleased to have assisted Sumagen in this important effort addressing the new priorities of the

This approval enables the company to begin marketing aegis products for sale in the EU. Peripatch aegis is a buttressing material designed to reinforce the staple line and

The issued patent, expiring in 2024, describes, in part, assays for the detection of methylation within a vimentin nucleotide sequence. Studies have demonstrated that methylation of vimentin DNA

The company expects that the new drug application (NDA) filing, if accepted, will be subject to standard review, which would provide a target for the FDA to complete

Lentigen and Expression Therapeutics will develop two types of treatments for hemophilia: a novel chimeric factor VIII protein for direct injection and a cell therapy that may permanently

Through this collaboration, Novavax intends to test the EB66 cell line for the production of virus like particle (VLP) vaccines against several new potential viruses. Rahul Singhvi, CEO